Fragment 176-191 is a synthetic peptide derived from human growth hormone (hGH), specifically designed to target fat metabolism. It promotes lipolysis (fat breakdown) and inhibits lipogenesis (fat formation), aiding in weight management without affecting blood sugar levels. Studies suggest potential benefits in obesity treatment and metabolic health.
12 in stock
Enhances fat breakdown while preventing new fat formation
Does not impact blood glucose or IGF-1 levels
May improve insulin sensitivity and metabolic function
Potential applications in obesity and metabolic disorder research
All products offered on this website are strictly intended for research and development purposes only. They are not for human consumption in any form.
The statements presented on this website have not been evaluated by the U.S. Food and Drug Administration (FDA). Neither the statements nor the products offered by this company are intended to diagnose, treat, cure, or prevent any disease.
Superhuman Peptides operates solely as a chemical supplier. It is not a compounding pharmacy or a chemical compounding facility as defined under Section 503A of the Federal Food, Drug, and Cosmetic Act. Superhuman Peptides is also not an outsourcing facility as defined under Section 503B of the same Act.
This website contains information about supplementary products. By entering, you confirm that you are of legal age (18 years or older) to access this information. If you are not of legal age, please leave this site immediately.
